GNC Holdings Inc (NYSE:GNC) has been given an average recommendation of “Hold” by the six analysts that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $3.13.
A number of brokerages have recently commented on GNC. ValuEngine raised Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research note on Friday, May 17th. Jefferies Financial Group cut their price target on Huntsman from $33.00 to $30.00 and set a “buy” rating on the stock in a research note on Monday, June 17th. Finally, Zacks Investment Research raised Hudson Technologies from a “sell” rating to a “hold” rating in a research note on Wednesday, May 29th.
Shares of GNC stock remained flat at $$1.87 during mid-day trading on Monday. The stock had a trading volume of 2,140,143 shares, compared to its average volume of 1,520,921. The business has a fifty day simple moving average of $1.54. GNC has a 12-month low of $1.32 and a 12-month high of $4.65. The firm has a market cap of $157.02 million, a PE ratio of 5.50 and a beta of 1.21.
Institutional investors have recently bought and sold shares of the stock. Alpha Omega Wealth Management LLC lifted its stake in shares of GNC by 183.0% in the first quarter. Alpha Omega Wealth Management LLC now owns 10,052 shares of the specialty retailer’s stock worth $27,000 after acquiring an additional 6,500 shares during the period. Comerica Bank bought a new stake in GNC in the fourth quarter worth approximately $33,000. Two Sigma Securities LLC bought a new stake in GNC in the fourth quarter worth approximately $51,000. FNY Investment Advisers LLC increased its holdings in GNC by 9,900.0% in the first quarter. FNY Investment Advisers LLC now owns 25,000 shares of the specialty retailer’s stock worth $68,000 after purchasing an additional 24,750 shares in the last quarter. Finally, Zacks Investment Management bought a new stake in GNC in the fourth quarter worth approximately $70,000. 52.82% of the stock is currently owned by institutional investors.
GNC Holdings, Inc, together with its subsidiaries, operates as a specialty retailer of health, wellness, and performance products. The company operates through three segments: U.S. and Canada, International, and Manufacturing/Wholesale. Its products include proteins, performance supplements, weight management supplements, vitamins, herbs and greens, wellness supplements, health and beauty products, food and drink products, and other general merchandise.
Recommended Story: NASDAQ Stock Market Explained
Receive News & Ratings for GNC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GNC and related companies with MarketBeat.com's FREE daily email newsletter.